ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use- Clarithromycin 250mg and 500mg

Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Clarithromycin 250mg and 500mg film-coated tablets.

 

MHRA drug alert date: 6th December 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strandhaven-ltd-t-slash-a-somex-pharma-clarithromycin-250mg-and-500mg-film-coated-tablets-el-23-a-slash-42

 

Pip code

Product

Supplier

Affected Batches

1178425

CLARITHROMYCIN TAB 250MG ACC

SOMEX/STRANDHAVEN

SEE ABOVE LINK

1148766

CLARITHROMYCIN TAB 250MG ALM

SOMEX/STRANDHAVEN

SEE ABOVE LINK

1178433

CLARITHROMYCIN TAB 500MG ACC

SOMEX/STRANDHAVEN

SEE ABOVE LINK

1148774

CLARITHROMYCIN TAB 500MG ALM

SOMEX/STRANDHAVEN

SEE ABOVE LINK

8112807

OTCD CLARITHROMYCIN TAB 250MG

SOMEX/STRANDHAVEN

SEE ABOVE LINK

8082463

OTCD CLARITHROMYCIN TAB 500MG

SOMEX/STRANDHAVEN

SEE ABOVE LINK

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For more information, medical information queries, contact: regulatory@somexpharma.com, tel: 020 8590 9399, choose option 3 or 4.

 

For stock control queries, contact: accounts@somexpharma.com, tel: 020 8590 9399, choose option 2.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use- Tramadol 50mg capsules

Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Tramadol Hydrochloride 50mg Capsules, Hard

 

 

MHRA drug alert date: 6th December 2023

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strandhaven-ltd-t-slash-a-somex-pharma-tramadol-hydrochloride-50mg-capsules-hard-el-23-a-slash-41?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=58cc3b9b-942b-448f-8503-aaeab8d73d7d&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

1115898

TRAMADOL CAP 50MG ALM (100)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

1140128

TRAMADOL CAP 50MG ALM (30)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

1065986

TRAMADOL CAP 50MG ACC (100)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

1085463

TRAMADOL CAP 50MG ACC (30)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

8082745

OTCD TRAMADOL CAP 50MG (30)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

8113250

OTCD TRAMADOL CAP 50MG (100)

STRANDHAVEN/SOMEX

SEE ABOVE LINK

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For more information, medical information queries, contact: regulatory@somexpharma.com, tel: 020 8590 9399, choose option 3 or 4.

 

For stock control queries, contact: accounts@somexpharma.com, tel: 020 8590 9399, choose option 2.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Caramet 25/100mg CR Tablet

Teva UK Limited, the Marketing Authorisation Holder (MAH) has informed the MHRA of a labelling error for the batch listed in this notification

 

MHRA drug alert date: 4th December 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-teva-uk-ltd-dot-caramet-25-slash-100mg-cr-tablets-el-23-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=fb44128a-df16-4382-837c-9ec3a1412da8&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

1133602

CARBIDOPA/LEVO CR 25/100MG TEV

TEVA UK LTD

23043965

 

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information queries, please contact Teva UK Limited Medical Information via phone on 0207 540 7117 or via email medinfo@tevauk.com.

 

For stock control queries, please contact Teva UK Limited Customer Solutions via phone on 0800 590502 or via email customer.services@tevauk.com.

SUB-TYPE:

Christmas 2023 and New Year Opening Hours

 

To help keep our customers informed of changes to our service, we have published our bank holiday opening hours for the 2023 Christmas and New Year period.

 

View our bank holiday opening hours:

 

Alliance Healthcare Christmas 2023 and New Year Opening Hours

 

Alliance Healthcare Christmas 2023 and New Year Opening Hours for Channel Islands and Isle of Man

 

Alcura Homecare Christmas 2023 and New Year Opening Hours

SUB-TYPE: CLASS 3 RECALL

Class 3 recall-Fluenz Tetra nasal spray suspension.

AstraZeneca UK Ltd. has informed the MHRA of an issue related to the expiry dates for certain batches of Fluenz Tetra. This recall provides further advice on the safe use of the product up to the amended expiry date.

 

 

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-astrazeneca-uk-ltd-dot-fluenz-tetra-nasal-spray-suspension-el-23-a-slash-39?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7d47971e-3b90-4324-907c-33274035a69c&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE HEALTHCARE DO NOT STOCK

FLUENZ TETRA LQD 0.2ML NS

  ASTRAZENECA

TH2127  TH2127B  TH3110  TH3110B  TJ2290B

TJ2290

 

Further information

For medical information enquiries please contact AstraZeneca Medical Information medical.informationUK@astrazeneca.com or call 0800 783 0033.

Fluenz Tetra remains available to order by NHS providers of the children’s flu programme in England and Wales via the ImmForm website (Helpdesk: 0207 183 8580 or Helpdesk@immform.org.uk).

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

SUB-TYPE: FIELD SAFETY NOTICE

Customer level recall-Specific brands of carbomer eye gel

Specific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination.

 

 

MHRA Drug alert link:

https://www.gov.uk/drug-device-alerts/specific-brands-of-carbomer-eye-gel-recall-of-aacarb-eye-gel-aacomer-eye-gel-and-puroptics-eye-gel-potential-risk-of-infection-dsi-slash-2023-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c596e044-f42d-4f51-8f4f-16dc07374147&utm_content=immediately

·  

Pip codeProduct descriptionSupplierBatch Numbers
4199311AACOMER 0.2% CARBOMER EYE GELESSENTIAL HEALTHCARE  SEE ABOVE LINK
4198883AACARB CARBOMER 0.2% EYE GELTRION PHARMA LIMITEDSEE ABOVE LINK
4232021PUROPTICS EYE GELBiovantic PharmaSEE ABOVE LINK
6328686CARBOMER GEL 0.2%SIGMASEE ABOVE LINK

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

SUB-TYPE:

World Antimicrobial Awareness Week 2023: Alliance Healthcare UK and Alphega Pharmacy Reiterate Their Commitment

 

Alliance Healthcare UK and Alphega Pharmacy are once more rallying behind World Antimicrobial Awareness Week (WAAW) this year. This marks a continuation of their support from the previous year, as they aim to tackle the global challenge of Antimicrobial Resistance (AMR).

 

The theme for WAAW 2023 is "Preventing Antimicrobial Resistance Together”. This decision was made after a comprehensive online consultation by the World Health Organisation, with stakeholders spanning human, animal, plant, and environmental health sectors in search of an impactful campaign theme.

 

This year's WAAW runs from the 18th till the 25th of November. The week-long initiative aspires to raise awareness about global antimicrobial resistance (AMR), driving best practices regarding antimicrobial usage to curtail the emergence and spread of drug-resistant infections.

 

Marie Evans, Managing Director, Alliance Healthcare said: “We are once again proud to be supporting AMR week to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices for using antimicrobials. It is important to continue to share awareness of this and pledge our support along with the NHS.”

 

The campaign alerts people that unnecessary intake of antibiotics could lead them towards having more serious or prolonged infections and strongly encourages adherence to doctor’s advice on antibiotic use.

 

amr

 

Support us and the NHS during World Antimicrobial Awareness Week

Alliance Healthcare continues its pledge to be an Antibiotic Guardian and is proud to support this campaign once more. Find out more here.

SUB-TYPE:

Alliance Healthcare UK and Alphega Pharmacy UK support Pharmacist Support’s ACTNow campaign

 

Alliance Healthcare UK and Alphega Pharmacy UK are once again proudly supporting Pharmacist Support’s ACTNow campaign.

The campaign supports pharmacists and pharmacy teams to encourage a mental health and wellbeing culture shift in the workplace, this year’s focus is to highlight real life workplace wellbeing practices that have made a positive impact.

 

ACTnow encourages individuals to:

 

  • - Allow time for wellbeing
  • - Consider the needs of others
  • - Take action

an3

 

In 2022, the ACTNow campaign achieved remarkable milestones, with a 49% increase in sign-ups and a 197% rise in social media engagement compared to the previous year. The campaign garnered over 16,000 website page views, reached a broader audience, including more male pharmacists, and received overwhelming positive feedback, with 88% of participants finding it very useful or useful, and 85% expressing the desire for future campaigns.

 

To find out more about the ACTNow Campaign please click here.

SUB-TYPE:

Alliance Healthcare Team Member Completes Blenheim Palace Triathlon in Aid of Cancer Research UK

 

Alliance Healthcare UK Chessington Support Centre team member, Roslyn Glover, has raised over £2,900 for Cancer Research UK taking part in this year’s Super Sprint Triathlon.

 

Roslyn was diagnosed and treated for breast cancer in 2019 and started running as part of her recovery. In 2020, she took part in the Race for Life 5km race and then, inspired by the GB Triathlon Team, Roslyn decided she would train for a triathlon.

 

The Super Sprint Triathlon is a 400-meter lake swim, 13.3km cycle and then a 2.9km run set in the grounds of UNESCO World Heritage Site Blenheim Palace. Each year, over 7,000 participants of all ages and abilities take part in the triathlon.

 

Roslyn finished the lake swim and closed road course in an impressive 1 hr 22 mins 51 secs this June.

 

The Cencora Foundation, the charitable giving arm of Alliance Healthcare’s parent company Cencora, is proud to show support for Roslyn by donating $2,500 USD bringing the total to almost £5,000. You can still donate here.

 

 

Ros Glover, AHUK customer finance team member, said:

“I was diagnosed and treated for breast cancer in 2019, so the Cancer Research charity is, quite literally, very close to my heart. I was inspired by the GB Triathlon Team at the Tokyo Olympics and set my sights on completing a triathlon with the ambition to raise funds for the charity. It was an incredible challenge but completing the race gave me a real sense of achievement. A huge thank you to everyone who sponsored and supported me.”

 

Sam Unsworth, Head of Communications at Alliance Healthcare UK, said:

“This is a fantastic achievement and Roslyn should be proud of the extraordinary sum she has raised for Cancer Research, which has been matched by the Cencora Foundation. We are pleased that so many Alliance Healthcare UK team members showed their support for Roslyn, and we look forward to seeing what challenge she takes on next.”

 

ros

SUB-TYPE: CLASS 4 CAUTION IN USE

class 4 caution in use- Zinacef Vials (all strengths)

Sandoz has detected that information on the diluents in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of cefuroxime contain incorrect information.

 

MHRA drug alert date: 23rd October 2023

 

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-limited-zinacef-powder-for-solution-for-injection-or-infusion-vials-all-strengths-including-stock-in-gsk-livery-el-23-a-slash-38?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=deab3b91-5e05-461a-94d7-cc812d40c9b7&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

0379552

ZINACEF INJ 250 MG

SANDOZ LTD

See above link

0379578

ZINACEF INJ 750 MG

SANDOZ LTD

See above link

0389361

ZINACEF INJ 1.5G

SANDOZ LTD

See above link

Alliance do not stock

ZINACEF INJ 250 MG

GSK

See above link

Alliance do not stock

ZINACEF INJ 750 MG

GSK

See above link

Alliance do not stock

ZINACEF INJ 1.5G

GSK

See above link

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For more information, medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101. For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607